Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours

Clinical trial NCT01161316 · COMPLETED

Trial details

NCT number: NCT01161316
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2010-08-01
Primary completion: 2015-06-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.